[1]
I. Eiras, I. Magalhães, and S. Martins, “Glucagon-like peptide-1 analog in the treatment of metabolic dysfunction-associated steatotic liver disease”, Int J Contemp Pediatr, vol. 13, no. 9, pp. 1841–1843, Aug. 2026.